Accelerating Therapeutic Antibody Discovery with Three Distinct Humanized Mouse Models

Accelerating Therapeutic Antibody Discovery with Three Distinct Humanized Mouse Models

August 31,2020 – Qingcong Lin, PhD

With a robust immune response, RenMab™ Mouse produces fully-human, functional antibodies of high antigen specificity and diverse epitopes. To identify leads, Biocytogen has created a catalog of target-humanized mouse models, allowing for researchers to conduct high throughput in vivo hit screening. Lastly, to further select for drug candidates with best clinical translation potential, Biocytogen offers immune-cell humanized mouse models for use in preclinical efficacy and toxicity evaluation.

Share:

Please fill out the form below to replay this Webinar